This website uses cookies. By using this website, you agree with the use of cookies. Privacy Policy Information
 
 
 

octenisept® vaginal therapeutic agent

Antiseptic for the treatment of vaginal infections

Downloads

Our Plus

  • treats the symptoms of itching, burning and discharge due to bacteria in the vaginal area
  • optimal moistening of the mucous membrane
  • no restriction on use in pregnant women from 4th month onwards
  • colourless
Expand All
Collapse All
Fields of Application
 
  • for the treatment of vaginal infections
  • for the alleviation of symptoms in case of itching, burning and discharge due to bacteria in the vaginal area
Instructions for use
 
Insert the vaginal applicator deeply into the vagina, pressing down the actuator cap of the applicator ten times one by one, in the morning and evening on the first day of treatment, then once a day in the evening. The period of treatment is seven days. Prior to first application, remove the protection and actuator cap from the bottle and keep it in a safe place, then take the applicator from the wrapping and place it on the bottle.
It is recommended to insert the applicator deep into the vagina while sitting on the toilet or lying in bed. Then, the cap of the applicator must be pressed down ten times one by one. After application, the applicator should be wiped off externally and some preparation should be sprayed out with the applicator facing down.
Before next application, some preparation should be sprayed out once or twice with the applicator facing down.
In order to prevent a renewed infection, the partner should be involved in the treatment. For this purpose, the preparation is to be sprayed, without applicator and with actuator cap placed on top, on the male genital until it is completely moistened.
If the symptoms persist and in case of relapse, a gynaecological examination incl. microbiologic diagnostics and, if required, antibiotic or antifungal therapy, is necessary.
Microbiological efficacy


octenisept® vaginal therapeutic agent is effective against:
  • bacteria including chlamydia and mycoplasmas
  • fungi and yeasts
  • protozoa (trichomonads)
  • virus (herpes simplex, HBV, HCV and HIV)
Product data
 
Composition:
100 g solution contain: active pharmaceutical ingredients: 0.1g octenidine dihydrochloride, 2.0g phenoxyethanol (Ph.Eur.)
Other ingredients: (3-coco fatty acid amidopropyl)-dimethlyazaniumylacetate, sodium-D-gluconate, glycerol 85%, sodium chloride, purified water, sodium hydroxide



Chemical-physical data

Flash point:Not applicable
Color:colourless
Density:ca. 1,005 g/cm3 / 20 °C
Form:liquid
pH:ca. 6 / 20 °C / concentrate
Special advice
 
  • octenisept® vaginal therapeutic agent should not be used to rinse the abdominal cavity (e.g. during operation), the urinary bladder and the nose and nor be applied to the eardrum.
  • Do not swallow octenisept® vaginal therapeutic agent in larger quantities, nor let it enter the bloodstream in larger quantities, e.g. by means of an inadvertent injection.
  • Do not mix octenisept® vaginal therapeutic agent with other preparations.
  • When applying octenisept® vaginal therapeutic agent, a momentary burning can occur as a subjective symptom in rare cases.
  • octenisept® vaginal therapeutic agent shall not be used after the expiration date. After the first use: Dispose the residual solution remaining in the container after termination of the treatment.
  • octenisept® vaginal therapeutic agent is to be kept out of reach of children.
  • Usage during pregnancy: It is the general medical principal that every administration of drugs should only be performed under strict medical diagnosis and monitoring.
Information for order
 
ItemDelivery formItem no.
octenisept Vag.thera.-CY/SYR- 50 ml FL20/Cartonon request
octenisept Vag.therap. 50 ml FL20/Cartonon request
These products are not available in every country. For more information please contact our local subsidiary or distributor.
Environmental information
 
schülke manufactures products economically and with advanced, safe and environmentally friendly production processes while at the same time maintaining out high quality standards.
octenisept® vaginal therapeutic agent

Composition: 100 g solution contain: octenidine dihydrochloride 0.1 g, phenoxyethanol (Ph.Eur.) 2.0 g. Other ingredients: (3-amidopropyl cocoate)
dimethylammonium acetate, sodium D-gluconate, glycerol 85%, sodium chloride, sodium hydroxide, purified water. - Indications: Antiseptic treatment of the vaginal area. Relief of symptoms of itching, burning and discharge caused by bacterial infection in the vaginal area. - Contraindications: octenisept® Vaginal Solution may not be used in cases of hypersensitivity to any of the components of the preparation. Adequate experience has not yet been gained concerning use in children below the age of 8 years. - Undesirable effects: In rare cases transient signs of local intolerance such as a slight burning sensation, redness or itching may occur at the application site. - Special warnings and special precautions for use: Do not swallow octenisept® Vaginal Solution and do not allow octenisept® Vaginal Solution to pass into the circulation, e.g. as a result of accidental injection. If any of the side effects gets serious, or if you notice any side effects not listed in this user information, please tell your doctor or pharmacist.
Manufacturer: Schülke & Mayr GmbH, 22840 Norderstedt, Germany, Tel. +49 40 52100-0, info@schuelke.com